Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus minimally invasive esophagectomy for resectable esophageal adenocarcinoma, a randomized controlled trial (ROBOT-2 trial)

Background: For patients with esophageal adenocarcinoma or cancer of the gastroesophageal junction, radical esophagectomy with 2-field lymphadenectomy is the cornerstone of the multimodality treatment with curative intent. Both conventional minimally invasive esophagectomy (MIE) and robot assisted m...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Tagkalos, Evangelos (VerfasserIn) , van der Sluis, P. C. (VerfasserIn) , Berlth, Felix (VerfasserIn) , Poplawski, A. (VerfasserIn) , Hadzijusufovic, E. (VerfasserIn) , Lang, H. (VerfasserIn) , van Berge Henegouwen, M. I. (VerfasserIn) , Gisbertz, S. S. (VerfasserIn) , Müller, Beat P. (VerfasserIn) , Ruurda, J. P. (VerfasserIn) , Schiesser, M. (VerfasserIn) , Schneider, P. M. (VerfasserIn) , van Hillegersberg, R. (VerfasserIn) , Grimminger, P. P. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 26 September 2021
In: BMC cancer
Year: 2021, Jahrgang: 21, Pages: 1-12
ISSN:1471-2407
DOI:10.1186/s12885-021-08780-x
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s12885-021-08780-x
Verlag, lizenzpflichtig, Volltext: https://bmccancer.biomedcentral.com/articles/10.1186/s12885-021-08780-x
Volltext
Verfasserangaben:E. Tagkalos, P.C. van der Sluis, F. Berlth, A. Poplawski, E. Hadzijusufovic, H. Lang, M.I. van Berge Henegouwen, S.S. Gisbertz, B.P. Müller-Stich, J.P. Ruurda, M. Schiesser, P.M. Schneider, R. van Hillegersberg and P.P. Grimminger

MARC

LEADER 00000caa a2200000 c 4500
001 1795130768
003 DE-627
005 20220820143355.0
007 cr uuu---uuuuu
008 220309s2021 xx |||||o 00| ||eng c
024 7 |a 10.1186/s12885-021-08780-x  |2 doi 
035 |a (DE-627)1795130768 
035 |a (DE-599)KXP1795130768 
035 |a (OCoLC)1341445847 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Tagkalos, Evangelos  |d 1982-  |e VerfasserIn  |0 (DE-588)1056846208  |0 (DE-627)794142370  |0 (DE-576)412851660  |4 aut 
245 1 0 |a Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus minimally invasive esophagectomy for resectable esophageal adenocarcinoma, a randomized controlled trial (ROBOT-2 trial)  |c E. Tagkalos, P.C. van der Sluis, F. Berlth, A. Poplawski, E. Hadzijusufovic, H. Lang, M.I. van Berge Henegouwen, S.S. Gisbertz, B.P. Müller-Stich, J.P. Ruurda, M. Schiesser, P.M. Schneider, R. van Hillegersberg and P.P. Grimminger 
264 1 |c 26 September 2021 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Published online: 26 September 2021 
500 |a Gesehen am 09.03.2022 
520 |a Background: For patients with esophageal adenocarcinoma or cancer of the gastroesophageal junction, radical esophagectomy with 2-field lymphadenectomy is the cornerstone of the multimodality treatment with curative intent. Both conventional minimally invasive esophagectomy (MIE) and robot assisted minimally invasive esophagectomy (RAMIE) were shown to be superior compared to open transthoracic esophagectomy considering postoperative complications. However, no randomized comparison exists between MIE and RAMIE in the Western World for patients with esophageal adenocarcinoma. Methods: This is an investigator-initiated and investigator-driven multicenter randomized controlled parallel-group superiority trial. All adult patients (age ≥ 18 and ≤ 90 years) with histologically proven, surgically resectable (cT1-4a, N0-3, M0) esophageal adenocarcinoma of the intrathoracic esophagus or adenocarcinoma of the gastroesophageal junction and with European Clinical Oncology Group performance status 0, 1 or 2 will be assessed for eligibility and included after obtaining informed consent. Patients (n = 218) with resectable esophageal adenocarcinoma of the intrathoracic esophagus or adenocarcinoma of the gastroesophageal junction are randomized to either RAMIE (n = 109) or MIE (n = 109). The primary outcome of this study is the total number of resected abdominal and mediastinal lymph nodes specified per lymph node station. 
700 1 |a van der Sluis, P. C.  |e VerfasserIn  |4 aut 
700 1 |a Berlth, Felix  |d 1985-  |e VerfasserIn  |0 (DE-588)1070600458  |0 (DE-627)824097882  |0 (DE-576)431927073  |4 aut 
700 1 |a Poplawski, A.  |e VerfasserIn  |4 aut 
700 1 |a Hadzijusufovic, E.  |e VerfasserIn  |4 aut 
700 1 |a Lang, H.  |e VerfasserIn  |4 aut 
700 1 |a van Berge Henegouwen, M. I.  |e VerfasserIn  |4 aut 
700 1 |a Gisbertz, S. S.  |e VerfasserIn  |4 aut 
700 1 |a Müller, Beat P.  |d 1971-  |e VerfasserIn  |0 (DE-588)14066209X  |0 (DE-627)70374819X  |0 (DE-576)317992287  |4 aut 
700 1 |a Ruurda, J. P.  |e VerfasserIn  |4 aut 
700 1 |a Schiesser, M.  |e VerfasserIn  |4 aut 
700 1 |a Schneider, P. M.  |e VerfasserIn  |4 aut 
700 1 |a van Hillegersberg, R.  |e VerfasserIn  |4 aut 
700 1 |a Grimminger, P. P.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t BMC cancer  |d London : BioMed Central, 2001  |g 21(2021), Artikel-ID 1060, Seite 1-12  |h Online-Ressource  |w (DE-627)326643710  |w (DE-600)2041352-X  |w (DE-576)107014645  |x 1471-2407  |7 nnas  |a Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus minimally invasive esophagectomy for resectable esophageal adenocarcinoma, a randomized controlled trial (ROBOT-2 trial) 
773 1 8 |g volume:21  |g year:2021  |g elocationid:1060  |g pages:1-12  |g extent:12  |a Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus minimally invasive esophagectomy for resectable esophageal adenocarcinoma, a randomized controlled trial (ROBOT-2 trial) 
856 4 0 |u https://doi.org/10.1186/s12885-021-08780-x  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://bmccancer.biomedcentral.com/articles/10.1186/s12885-021-08780-x  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220309 
993 |a Article 
994 |a 2021 
998 |g 14066209X  |a Müller, Beat P.  |m 14066209X:Müller, Beat P.  |d 910000  |d 910200  |d 50000  |e 910000PM14066209X  |e 910200PM14066209X  |e 50000PM14066209X  |k 0/910000/  |k 1/910000/910200/  |k 0/50000/  |p 9 
999 |a KXP-PPN1795130768  |e 4084719188 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Published online: 26 September 2021","Gesehen am 09.03.2022"],"id":{"eki":["1795130768"],"doi":["10.1186/s12885-021-08780-x"]},"title":[{"title":"Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus minimally invasive esophagectomy for resectable esophageal adenocarcinoma, a randomized controlled trial (ROBOT-2 trial)","title_sort":"Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus minimally invasive esophagectomy for resectable esophageal adenocarcinoma, a randomized controlled trial (ROBOT-2 trial)"}],"recId":"1795130768","language":["eng"],"origin":[{"dateIssuedDisp":"26 September 2021","dateIssuedKey":"2021"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"relHost":[{"recId":"326643710","pubHistory":["1.2001 -"],"id":{"issn":["1471-2407"],"eki":["326643710"],"zdb":["2041352-X"]},"title":[{"title":"BMC cancer","title_sort":"BMC cancer"}],"note":["Gesehen am 22.05.20"],"disp":"Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus minimally invasive esophagectomy for resectable esophageal adenocarcinoma, a randomized controlled trial (ROBOT-2 trial)BMC cancer","language":["eng"],"origin":[{"publisher":"BioMed Central ; Springer","publisherPlace":"London ; Berlin ; Heidelberg","dateIssuedKey":"2001","dateIssuedDisp":"2001-"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"part":{"pages":"1-12","year":"2021","extent":"12","volume":"21","text":"21(2021), Artikel-ID 1060, Seite 1-12"},"physDesc":[{"extent":"Online-Ressource"}]}],"person":[{"roleDisplay":"VerfasserIn","family":"Tagkalos","given":"Evangelos","role":"aut","display":"Tagkalos, Evangelos"},{"given":"P. C.","role":"aut","display":"van der Sluis, P. C.","family":"van der Sluis","roleDisplay":"VerfasserIn"},{"family":"Berlth","roleDisplay":"VerfasserIn","given":"Felix","role":"aut","display":"Berlth, Felix"},{"role":"aut","display":"Poplawski, A.","given":"A.","family":"Poplawski","roleDisplay":"VerfasserIn"},{"display":"Hadzijusufovic, E.","role":"aut","given":"E.","roleDisplay":"VerfasserIn","family":"Hadzijusufovic"},{"roleDisplay":"VerfasserIn","family":"Lang","given":"H.","display":"Lang, H.","role":"aut"},{"family":"van Berge Henegouwen","roleDisplay":"VerfasserIn","given":"M. I.","display":"van Berge Henegouwen, M. I.","role":"aut"},{"family":"Gisbertz","roleDisplay":"VerfasserIn","given":"S. S.","display":"Gisbertz, S. S.","role":"aut"},{"given":"Beat P.","role":"aut","display":"Müller, Beat P.","family":"Müller","roleDisplay":"VerfasserIn"},{"given":"J. P.","display":"Ruurda, J. P.","role":"aut","roleDisplay":"VerfasserIn","family":"Ruurda"},{"roleDisplay":"VerfasserIn","family":"Schiesser","given":"M.","role":"aut","display":"Schiesser, M."},{"roleDisplay":"VerfasserIn","family":"Schneider","display":"Schneider, P. M.","role":"aut","given":"P. M."},{"role":"aut","display":"van Hillegersberg, R.","given":"R.","roleDisplay":"VerfasserIn","family":"van Hillegersberg"},{"role":"aut","display":"Grimminger, P. P.","given":"P. P.","family":"Grimminger","roleDisplay":"VerfasserIn"}],"name":{"displayForm":["E. Tagkalos, P.C. van der Sluis, F. Berlth, A. Poplawski, E. Hadzijusufovic, H. Lang, M.I. van Berge Henegouwen, S.S. Gisbertz, B.P. Müller-Stich, J.P. Ruurda, M. Schiesser, P.M. Schneider, R. van Hillegersberg and P.P. Grimminger"]},"physDesc":[{"extent":"12 S."}]} 
SRT |a TAGKALOSEVROBOTASSIS2620